Non-vitamin K antagonist oral anticoagulants in the cardioversion of patients with atrial fibrillation: systematic review and meta-analysis

被引:0
作者
Daniel Caldeira
João Costa
Joaquim J. Ferreira
Gregory Y. H. Lip
Fausto J. Pinto
机构
[1] Instituto de Medicina Molecular,Clinical Pharmacology Unit
[2] Faculdade de Medicina da Universidade de Lisboa,Laboratório de Farmacologia Clínica e Terapêutica
[3] Hospital Garcia de Orta,Cardiology Department
[4] Portuguese Collaborating Center of the Iberoamerican Cochrane Network,Evidence Based Medicine Centre, Faculty of Medicine
[5] University of Lisbon,Cardiology Department
[6] University of Birmingham Centre for Cardiovascular Sciences,undefined
[7] City Hospital,undefined
[8] CCUL,undefined
[9] CAML,undefined
[10] Faculty of Medicine,undefined
来源
Clinical Research in Cardiology | 2015年 / 104卷
关键词
Meta-analysis; Electric countershock; Stroke; Anticoagulants; Cardioversion; Transesophageal echocardiography;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:582 / 590
页数:8
相关论文
共 182 条
[11]  
Bjerkelund CJ(2002)Issues in the selection of a summary statistic for meta-analysis of clinical trials with binary outcomes Stat Med 295 676-136
[12]  
Orning OM(1997)Bias in meta-analysis detected by a simple, graphical test BMJ 123 131-2006
[13]  
Caldeira D(2006)Comparison of two methods to detect publication bias in meta-analysis JAMA 61 1998-1087
[14]  
Barra M(2011)Dabigatran versus warfarin in patients with atrial fibrillation: an analysis of patients undergoing cardioversion Circulation 63 1082-77
[15]  
Pinto FJ(2013)Outcomes after cardioversion and atrial fibrillation ablation in patients treated with rivaroxaban and warfarin in the ROCKET AF trial J Am Coll Cardiol 26 53-855
[16]  
Ferreira JJ(2014)Efficacy and safety of apixaban in patients after cardioversion for atrial fibrillation: insights from the ARISTOTLE Trial (Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation) J Am Coll Cardiol 19 851-1547
[17]  
Costa J(2014)Rivaroxaban vs. vitamin K antagonists for cardioversion in atrial fibrillation Eur Heart J 82 1545-261
[18]  
Caldeira D(2007)Much ado about nothing: a comparison of the performance of meta-analytical methods with rare events Stat Med 5 257-154
[19]  
Barra M(1992)Role of prophylactic anticoagulation for direct current cardioversion in patients with atrial fibrillation or atrial flutter J Am Coll Cardiol 20 148-651
[20]  
Santos AT(1998)Timing of thromboembolic events after electrical cardioversion of atrial fibrillation or flutter: a retrospective analysis Am J Cardiol 15 625-182